Evaluation of Microbial-derived TMAO Production From Carnitine Intake by Testing Fecal Bbu Gene
Gut Dysbiosis for TMAO Production From L-carnitine Consumption
About this trial
This is an interventional basic science trial for Gut Dysbiosis for TMAO Production From L-carnitine Consumption
Eligibility Criteria
Inclusion Criteria: Adult with age between 18 to 70 Must be able to swallow tablets Exclusion Criteria: Antibiotics use within one month L-carnitine supplement use within one month Chronic diarrhea Myasthenia gravis Diabetes mellitus Parathyroid disorders Chronic kidney disease Epilepsy Severe anemia Cardiovascular diseases.
Sites / Locations
- National Taiwan University HospitalRecruiting
Arms of the Study
Arm 1
Experimental
L-Carnitine supplementation
Participants are required to take a capsule containing 500mg L-carnitine/day continuous for 7-10 days. During the intervention, participants are asked to collect urine sample and dietary record each day. Blood and fecal samples will be collected before and after the intervention. Each participant needs to complete a food frequency questionnaire.